What are the considerations for using Diphenhydramine (Benadryl) in a patient with End-Stage Renal Disease (ESRD) undergoing hemodialysis?

Diphenhydramine Use in ESRD Patients on Hemodialysis

Diphenhydramine should be avoided in patients with end-stage renal disease undergoing hemodialysis due to increased risk of sedation, falls, and potential long-term cognitive impairment, with safer alternatives available for most indications. 1

Why Diphenhydramine is Problematic in ESRD

Pharmacokinetic concerns make diphenhydramine particularly dangerous in this population:

• Diphenhydramine is highly protein-bound (>95% albumin binding), which severely limits its removal by hemodialysis and predisposes patients to drug accumulation and toxicity 2
• The drug's inability to be dialyzed means that standard dosing leads to prolonged exposure and enhanced side effects in ESRD patients 2
• First-generation antihistamines like diphenhydramine carry increased risk of sedation, falls, and with chronic use, may predispose to dementia 1
• There is a fundamental lack of safety data and appropriate dosing guidelines specifically for the ESRD population 2

Safer Alternatives Based on Indication

For Allergic Reactions or General Antihistamine Needs:

• Fexofenadine is the preferred second-generation antihistamine due to minimal sedating effects compared to other antihistamines 1
• Loratadine may be used with caution in severe renal impairment, though specific dose adjustments are less clearly defined 1
• Avoid cetirizine and levocetirizine entirely in severe renal impairment (creatinine clearance <10 mL/min) 1

For Uremic Pruritus (Most Common ESRD Indication):

Antihistamines have limited efficacy for uremic pruritus and should not be first-line therapy 1

Preferred treatment algorithm:

1. Gabapentin 100-300 mg after dialysis three times weekly - shows superior efficacy compared to antihistamines 1
2. Ketotifen 1 mg daily may be considered as an alternative antihistamine with some evidence for uremic pruritus 1
3. Non-pharmacological approaches should always be implemented first:
   • Ensure adequate dialysis with target Kt/V around 1.6 1
   • Normalize calcium-phosphate balance and control parathyroid hormone 1
   • Apply emollients liberally for xerosis (dry skin) 1
   • Consider high-flux hemodialysis over standard hemodialysis filtration 1

For Anxiety or Sedation Needs:

• Lorazepam is the safest benzodiazepine choice in ESRD because it undergoes hepatic glucuronidation (not renal clearance), and its glucuronide metabolite is inactive 3
• Diazepam and midazolam also require no dose adjustment as they undergo hepatic metabolism 4
• Critical caveat: When using IV lorazepam, monitor for propylene glycol accumulation (the vehicle), which can cause metabolic acidosis at doses as low as 1 mg/kg total daily dose 3
• Monitor serum osmol gap, with values >10-12 mOsm/L suggesting propylene glycol toxicity 3

Key Clinical Pitfalls to Avoid

• Do not assume hemodialysis will "clear" diphenhydramine - its high protein binding prevents effective dialytic removal 2
• Recognize that nonrenal drug clearance is also substantially decreased in CKD/ESRD, not just renal excretion, leading to unexpected drug accumulation even for "hepatically cleared" medications 5
• Avoid the common mistake of using antihistamines as first-line for uremic pruritus - they are generally ineffective for this indication 1
• Case reports document diphenhydramine abuse and toxicity in dialysis patients, highlighting the need for careful prescribing and monitoring 2

If Diphenhydramine Must Be Used (Last Resort Only)

Given the lack of established dosing guidelines and safety data 2, if no alternative exists:

• Use the lowest possible dose
• Extend dosing intervals significantly beyond standard recommendations
• Monitor closely for excessive sedation, confusion, and falls
• Consider checking drug levels if available
• Reassess necessity frequently and discontinue as soon as possible